Cargando…
Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of response to endocrine treatment in breast cancer
Autores principales: | Soon, YH, Bane, F, Hughes, E, Young, LS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306072/ http://dx.doi.org/10.1186/1753-6561-9-S1-A52 |
Ejemplares similares
-
Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy
por: McIlroy, M, et al.
Publicado: (2010) -
HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients
por: Chang, Shih-Lun, et al.
Publicado: (2017) -
Role of HOXC10 in Cancer
por: Fang, Jinyong, et al.
Publicado: (2021) -
The Significance of HOXC11 and LSH in Survival Prediction in Gastric Adenocarcinoma
por: Peng, Xin, et al.
Publicado: (2021) -
HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib
por: deBlacam, C, et al.
Publicado: (2011)